100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
NR511 Final Exam Study Guide (Latest-2022, Version-2) / NR 511 Final Exam Study Guide / NR511 Week 8 Final Exam Study Guide: Differential Diagnosis and Primary Care Practicum: Chamberlain College of Nursing |Latest and Updated Guide|$15.49
Add to cart
NR511: Differential Diagnosis & Primary Care Pract
Exam (elaborations)
NR511 Final Exam Study Guide (Latest-2022, Version-2) / NR 511 Final Exam Study Guide / NR511 Week 8 Final Exam Study Guide: Differential Diagnosis and Primary Care Practicum: Chamberlain College of Nursing |Latest and Updated Guide|
13 views 0 purchase
Course
NR511: Differential Diagnosis & Primary Care Pract
Institution
Chamberlain College Of Nursing
NR511 Final Exam Study Guide (Latest-2022, Version-1) / NR 511 Final Exam Study Guide / NR511 Week 8 Final Exam Study Guide: Differential Diagnosis and Primary Care Practicum: Chamberlain College of Nursing |Latest and Updated Guide|
version 1 nr 511 final exam study guide nr511 week 8 final exam study guide differential diagnosis and primary care practicum chamberlain college of n
Written for
Chamberlain College Of Nursing
NR511: Differential Diagnosis & Primary Care Pract
All documents for this subject (19)
Seller
Follow
waldenquiz
Reviews received
Content preview
1
,2
, Poststreptococcal glomerulonephritis is a serious complication of impetigo (ecthyma).
This condition develops within 1–2 weeks following infection. Poststreptococcal
glomerulonephritis manifests with edema, hypertension, fever, and hematuria.
The diagnosis of impetigo often can be made on the basis of clinical manifestations.
A Gram stain and culture of pus or exudate is recommended to identify whether S.
aureus and/or a beta-hemolytic Streptococcus is the cause. However, treatment may be
initiated without these studies in patients with typical clinical presentations.
Bullous and nonbullous impetigo can be treated with either topical or oral therapy.
Topical therapy is used for patients with limited skin involvement whereas oral therapy is
recommended for patients with numerous lesions. Unlike impetigo, ecthyma should
always be treated with oral therapy.
Benefits of topical therapy include fewer side effects and lower risk for contributing to
bacterial resistance compared with oral therapy. Topical choices to treat impetigo
include the following medications for 5 days.
• Mupirocin three times daily
• Retapamulin twice daily
Extensive impetigo and ecthyma should be treated with an antibiotic effective for both S.
aureus and streptococcal infections unless cultures reveal only streptococci. Dicloxacillin
and cephalexin are appropriate treatments. A 7-day course of oral antibiotic treatment is
recommended. If only streptococci are detected in extensive impetigo or ecthyma, oral
penicillin is the preferred therapy.
MRSA impetigo can be treated with doxycycline, clindamycin, or trimethoprim-
sulfamethoxazole (Bactrim). Crusted lesions can be washed gently. Children can return
to school 24 hours after beginning an effective antimicrobial therapy. Draining lesions
should be kept covered.
Quiz:Sally, aged 25, presents with impetigo that has been diagnosed as infected with
staphylococcus. The clinical presentation is pruritic tender, red vesicles surrounded
by erythema with a rash that is ulcerating. She has not been adequately treated
recently. Which type of impetigo is this?
a. Bullous impetigo
b. Staphylococcal scalded skin syndrome (SSSS)
c. Nonbullous impetigo
d. Ecthyma
2. Staphylococcal Scalded Skin Syndrome
Caused by Staphylococcus aureus, it’s a variant of bullous impetigo:Epidermal necrosis
caused by bacterial exotoxins, resulting in the epithelial layer peeling off in large,
sheetlike pieces; mimics scalded-skin thermal burn.This serious infection is more
commonly seen in children and usually begins in the intertriginous areas.
3. Cellulitis
, Cellulitis is an acute infection as a result of bacterial entry via breaches in the skin
barrier. As the bacteria enter the subcutaneous tissues, their toxins are released which
causes an inflammatory response.
Cellulitis and erysipelas is almost always a unilateral infection with the most
common site of infection being the lower extremities.
Cellulitis involves the deeper dermis and subcutaneous fat.
Cellulitis is observed most frequently among middle-aged individuals and older
adults.
The vast majority of pathogens associated with cellulitis are from either
Streptococcus or Staphlococcus bacteria. The most common are beta-hemolytic
streptococci (groups A, B, C, G, and F), and S. aureus (gram +)
Both erysipelas and cellulitis manifest with areas of skin erythema, edema,
warmth and pain. Fever may be present. Additional manifestations of cellulitis
and erysipelas include lymphangitis and inflammation of regional lymph nodes.
Edema surrounding the hair follicles may lead to dimpling in the skin, creating an
appearance reminiscent of an orange peel texture called "peaud'orange".
Cellulitis may present with or without purulence
patients with cellulitis tend to have a more indolent course with development of
localized symptoms over a few days.
Many patients with cellulitis have underlying such as tinea pedis, lymphedema,
and chronic venous insufficiency. In such patients, treatment should be directed
at both the infection and the predisposing condition if modifiable.
Patients with cellulitis or erysipelas in the absence of abscess or purulent
drainage should be managed with empiric antibiotic therapy. Patients with
drainable abscess should undergo incision and drainage.
I. Describe an appropriate empiric antibiotic treatment plan for cellulitis
should be managed with empiric therapy for infection due to beta-hemolytic
streptococci and methicillin-susceptible Staphylococcus aureus (MSSA) with:
• Cephalexin 500 mg four times daily (alternative for mild penicillin allergy)
• Clindamycin 300 mg to 450 mg four times daily (alternative for severe penicillin
allergy)
Good choices for uncomplicated cases of cellulitis that are not associated with
human or animal bites include dicloxacillin or cephalexin for 10 to 14 days.
If pt has severe PCN allergy rx erythromycin
If caused by animal or human bite: amoxicillin-clavulanic acid (augmentin) for 2
weeks
The coverage for MRSA is achieved by adding to amoxicillin one of the following:
Bactrim DS twice daily
Doxycycline 100 mg twice daily
Minocycline 200 mg orally once, then 100 mg orally every 12 hours
If clindamycin is used, no additional MRSA coverage is needed.
Risk factors for community-associated methicillin-resistant S. aureus (CA-MRSA) include the
following.
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller waldenquiz. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $15.49. You're not tied to anything after your purchase.
